Skip to main content
TRVI filings

Corporate insider profile

Michael Thomas Heffernan Filing Activity

Latest reported as Director of Trevi Therapeutics, Inc. (TRVI).

Purchase filings
0
Reported companies
1
Net open-market value
-$595,805.46
Latest transaction
Sep 15, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 15, 2026Trevi Therapeutics, Inc. (TRVI)DirectorSale39,473$15.09$595,805